摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-3-(8-Dimethylamino-2,7,8,9-tetrahydro-6-oxa-2-azabenzo[cd]azulen-5-yl)-acrylic acid methyl ester

中文名称
——
中文别名
——
英文名称
(E)-3-(8-Dimethylamino-2,7,8,9-tetrahydro-6-oxa-2-azabenzo[cd]azulen-5-yl)-acrylic acid methyl ester
英文别名
(E)-3-(8-dimethylamino-2,7,8,9-tetrahydro-6-oxa-2-azabenzo[c,d]azulen-5-yl)acrylic acid methyl ester;methyl (E)-3-[11-(dimethylamino)-9-oxa-3-azatricyclo[6.4.1.04,13]trideca-1,4(13),5,7-tetraen-7-yl]prop-2-enoate
(E)-3-(8-Dimethylamino-2,7,8,9-tetrahydro-6-oxa-2-azabenzo[cd]azulen-5-yl)-acrylic acid methyl ester化学式
CAS
——
化学式
C17H20N2O3
mdl
——
分子量
300.357
InChiKey
KPGQNAWFGNANFJ-FNORWQNLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    54.6
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    7-bromo-N,N-dimethyl-9-oxa-3-azatricyclo[6.4.1.04,13]trideca-1,4(13),5,7-tetraen-11-amine丙烯酸甲酯(MA) 在 bis-triphenylphosphine-palladium(II) chloride 三乙胺 作用下, 以 DMF (N,N-dimethyl-formamide) 为溶剂, 反应 19.0h, 以47%的产率得到(E)-3-(8-Dimethylamino-2,7,8,9-tetrahydro-6-oxa-2-azabenzo[cd]azulen-5-yl)-acrylic acid methyl ester
    参考文献:
    名称:
    Tricylic indole compounds having affinity for serotonin receptor
    摘要:
    针对5-羟色胺受体具有亲和力的化合物(I),如下所示,可用作治疗中枢神经系统各种疾病的治疗剂。其中R1为氢;R2为氢或较低的烷基;R3为氢,—COOR12等;R4为氢,较低的烷基等,或者R3和R4一起可能形成═O或═S;R5为氢,或者R3和R5一起可能形成键;R6为氢,—COOR24等;R7为氢,卤素,较低的烷基等;R8为氢,较低的烷基,环烷基等;R9、R10和R11各自独立地为氢,卤素,较低的烷基等。
    公开号:
    US20030236295A1
点击查看最新优质反应信息

文献信息

  • Tricyclic indole compounds having an affinity against serotonin receptors
    申请人:Fukui Yoshikazu
    公开号:US20050043387A1
    公开(公告)日:2005-02-24
    Having an affinity against serotonine receptors, compound (I) shown below is useful as a therapeutic agent against various kinds of diseases of central nervous systems. (wherein R 1 is hydrogen; R 2 is hydrogen or lower alkyl; R 3 is hydrogen, —COOR 12 and so on; R 4 is hydrogen, lower alkyl and so on, or R 3 and R 4 taken together may form ═O or ═S; R 5 is hydrogen, or R 3 and R 5 taken together may form a bond; R 6 is hydrogen, —COOR 24 and so on; R 7 is hydrogen, halogen, lower alkyl and so on; R 8 is hydrogen, lower alkyl, cycloalkyl and so on; R 9 , R 10 and R 11 are each independently hydrogen, halogen, lower alkyl and so on)
    以下化合物(I)具有对5-羟色胺受体的亲和性,因此可用作治疗中枢神经系统各种疾病的治疗剂。(其中R1为氢;R2为氢或低碳基;R3为氢,-COOR12等;R4为氢,低碳基等,或R3和R4可共同形成═O或═S;R5为氢,或者R3和R5共同形成键;R6为氢,-COOR24等;R7为氢,卤素,低碳基等;R8为氢,低碳基,环烷基等;R9,R10和R11各自独立地为氢,卤素,低碳基等)
  • TRICYCLIC INDOLE COMPOUNDS HAVING AFFINITY FOR SEROTONIN RECEPTOR
    申请人:SHIONOGI & CO., LTD.
    公开号:EP1325909A1
    公开(公告)日:2003-07-09
    Having an affinity against serotonine receptors, compound (I) shown below is useful as a therapeutic agent against various kinds of diseases of central nervous systems. (wherein R1 is hydrogen ; R2 is hydrogen or lower alkyl ; R3 is hydrogen,-COOR12 and so on ; R4 is hydrogen, lower alkyl and so on, or R3 and R4 taken together may form =O or =S; R5 is hydrogen, or R3 and R5 taken together may form a bond ; R6is hydrogen, -COOR24 and so on ; R7 is hydrogen, halogen, lower alkyl and so on ; R8 is hydrogen, lower alkyl, cycloalkyl and so on ; R9, R10 and R11 are each independently hydrogen, halogen, lower alkyl and so on)
    下图所示化合物(I)对血清素受体具有亲和力,可用作治疗各种中枢神经系统疾病的药物。 (其中 R1 是氢;R2 是氢或低级烷基;R3 是氢、-COOR12 等;R4 是氢、低级烷基等,或 R3 和 R4 合在一起可形成 =O 或 =S;R5 是氢,或 R3 和 R5 合在一起可形成键;R6 是氢、-COOR24 等;R7 是氢、卤素、低级烷基等;R8 是氢、低级烷基、环烷基等;R9、R10 和 R11 各自独立地是氢、卤素、低级烷基等)。
  • US6858640B2
    申请人:——
    公开号:US6858640B2
    公开(公告)日:2005-02-22
  • Tricylic indole compounds having affinity for serotonin receptor
    申请人:——
    公开号:US20030236295A1
    公开(公告)日:2003-12-25
    Having an affinity against serotonine receptors, compound (I) shown below is useful as a therapeutic agent against various kinds of diseases of central nervous systems. 1 (wherein R 1 is hydrogen; R 2 is hydrogen or lower alkyl; R 3 is hydrogen, —COOR 12 and so on; R 4 is hydrogen, lower alkyl and so on, or R 3 and R 4 taken together may form ═O or ═S; R 5 is hydrogen, or R 3 and R 5 taken together may form a bond; R 6 is hydrogen, —COOR 24 and so on; R 7 is hydrogen, halogen, lower alkyl and so on; R 8 is hydrogen, lower alkyl, cycloalkyl and so on; R 9 , R 10 and R 11 are each independently hydrogen, halogen, lower alkyl and so on)
    针对5-羟色胺受体具有亲和力的化合物(I),如下所示,可用作治疗中枢神经系统各种疾病的治疗剂。其中R1为氢;R2为氢或较低的烷基;R3为氢,—COOR12等;R4为氢,较低的烷基等,或者R3和R4一起可能形成═O或═S;R5为氢,或者R3和R5一起可能形成键;R6为氢,—COOR24等;R7为氢,卤素,较低的烷基等;R8为氢,较低的烷基,环烷基等;R9、R10和R11各自独立地为氢,卤素,较低的烷基等。
查看更多